a public good project by the
Synthesis
Company
of California

© 2026

Raf Sciot | doi.page

0 works0 citations0 h-index

Raf Sciot

KU Leuven(BE)

Publications by Year

Research Areas

Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Bone Tumor Diagnosis and Treatments, Soft tissue tumor case studies, Gastric Cancer Management and Outcomes

Most-Cited Works

→ Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21(2006)1,517 cited
→ Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study(2001)1,270 cited
→ Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease(2005)1,065 cited
→ Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration(2001)1,009 cited
→ KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours(2006)894 cited
→ Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO(2005)720 cited

→ Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization(2021)

640 cited

→ The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25(2001)616 cited

→ Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome(2011)547 cited

→ 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)(2003)526 cited